{"count": 4, "results": [{"_id": "36685490", "pmid": 36685490, "pmcid": "PMC9849361", "title": "Lisinopril prevents bullous pemphigoid induced by dipeptidyl peptidase 4 inhibitors via the Mas receptor pathway", "journal": "Front Immunol", "authors": ["Nozawa K", "Suzuki T", "Kayanuma G", "Yamamoto H", "Nagayasu K", "Shirakawa H", "Kaneko S"], "date": "2023-01-05T00:00:00Z", "doi": "10.3389/fimmu.2022.1084960", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "1084960", "score": 50277.24, "text_hl": "@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ prevents @<m>DISEASE_Pemphigoid_Bullous</m> @DISEASE_MESH:D010391 @@@bullous pemphigoid@@@ induced by @GENE_DPP4 @GENE_1803 @@@dipeptidyl peptidase 4@@@ inhibitors via the @GENE_MAS1L @GENE_116511 @@@Mas receptor@@@ pathway", "citations": {"NLM": "Nozawa K, Suzuki T, Kayanuma G, Yamamoto H, Nagayasu K, Shirakawa H, Kaneko S. Lisinopril prevents bullous pemphigoid induced by dipeptidyl peptidase 4 inhibitors via the Mas receptor pathway Front Immunol. 2022;13():1084960. PMID: 36685490", "BibTeX": "@article{36685490, title={Lisinopril prevents bullous pemphigoid induced by dipeptidyl peptidase 4 inhibitors via the Mas receptor pathway}, author={Nozawa K and Suzuki T and Kayanuma G and Yamamoto H and Nagayasu K and Shirakawa H and Kaneko S}, journal={Front Immunol}, volume={13}, pages={1084960}}"}}, {"_id": "38296548", "pmid": 38296548, "title": "A Novel Strategy for the Discovery of Drug Targets: Integrating Clinical Evidence with Molecular Studies.", "journal": "Biol Pharm Bull", "authors": ["Kaneko S"], "date": "2024-01-01T00:00:00Z", "doi": "10.1248/bpb.b23-00831", "meta_date_publication": "2024", "meta_volume": "47", "meta_issue": "2", "meta_pages": "345-349", "score": 50247.79, "text_hl": "Pharmacological studies using animal models have mimicked this phenomenon and revealed the molecular mechanisms associated with the platelet-derived growth factor-alpha receptors. (2) The antidiabetic dipeptidyl-peptidase 4 inhibitors increased the risk of an @DISEASE_Autoimmune_Diseases @DISEASE_MESH:D001327 @@@autoimmune disease@@@, @<m>DISEASE_Pemphigoid_Bullous</m> @DISEASE_MESH:D010391 @@@bullous pemphigoid@@@, which was reduced by the concomitant use of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@. ", "citations": {"NLM": "Kaneko S. A Novel Strategy for the Discovery of Drug Targets: Integrating Clinical Evidence with Molecular Studies. Biol Pharm Bull. 2024;47(2):345-349. PMID: 38296548", "BibTeX": "@article{38296548, title={A Novel Strategy for the Discovery of Drug Targets: Integrating Clinical Evidence with Molecular Studies.}, author={Kaneko S}, journal={Biol Pharm Bull}, volume={47}, number={2}, pages={345-349}}"}}, {"_id": "16965449", "pmid": 16965449, "title": "Can pemphigoid be provoked by lisinopril?", "journal": "Br J Dermatol", "authors": ["Kalińska-Bienias A", "Rogoziński TT", "Woźniak K", "Kowalewski C"], "date": "2006-10-01T00:00:00Z", "doi": "10.1111/j.1365-2133.2006.07453.x", "meta_date_publication": "2006 Oct", "meta_volume": "155", "meta_issue": "4", "meta_pages": "854-5", "score": 50107.312, "text_hl": "Can @<m>DISEASE_Pemphigoid_Bullous</m> @DISEASE_MESH:D010391 @@@pemphigoid@@@ be provoked by @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@?", "citations": {"NLM": "Kalińska-Bienias A, Rogoziński TT, Woźniak K, Kowalewski C. Can pemphigoid be provoked by lisinopril? Br J Dermatol. 2006 Oct;155(4):854-5. PMID: 16965449", "BibTeX": "@article{16965449, title={Can pemphigoid be provoked by lisinopril?}, author={Kalińska-Bienias A and Rogoziński TT and Woźniak K and Kowalewski C}, journal={Br J Dermatol}, volume={155}, number={4}, pages={854-5}}"}}, {"_id": "30155951", "pmid": 30155951, "title": "Lisinopril-associated bullous pemphigoid in an elderly woman: a case report of a rare adverse drug reaction.", "journal": "Br J Clin Pharmacol", "authors": ["Ballout RA", "Musharrafieh U", "Khattar J"], "date": "2018-11-01T00:00:00Z", "doi": "10.1111/bcp.13737", "meta_date_publication": "2018 Nov", "meta_volume": "84", "meta_issue": "11", "meta_pages": "2678-2682", "score": 50074.113, "text_hl": "@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@-associated @<m>DISEASE_Pemphigoid_Bullous</m> @DISEASE_MESH:D010391 @@@bullous pemphigoid@@@ in an elderly @SPECIES_9606 @@@woman@@@: a case report of a rare @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@adverse drug reaction@@@.", "citations": {"NLM": "Ballout RA, Musharrafieh U, Khattar J. Lisinopril-associated bullous pemphigoid in an elderly woman: a case report of a rare adverse drug reaction. Br J Clin Pharmacol. 2018 Nov;84(11):2678-2682. PMID: 30155951", "BibTeX": "@article{30155951, title={Lisinopril-associated bullous pemphigoid in an elderly woman: a case report of a rare adverse drug reaction.}, author={Ballout RA and Musharrafieh U and Khattar J}, journal={Br J Clin Pharmacol}, volume={84}, number={11}, pages={2678-2682}}"}}]}